Literature DB >> 18582621

Decision-making when data and inferences are not conclusive: risk-benefit and acceptable regret approach.

Iztok Hozo1, Michael J Schell, Benjamin Djulbegovic.   

Abstract

The absolute truth in research is unobtainable, as no evidence or research hypothesis is ever 100% conclusive. Therefore, all data and inferences can in principle be considered as "inconclusive." Scientific inference and decision-making need to take into account errors, which are unavoidable in the research enterprise. The errors can occur at the level of conclusions that aim to discern the truthfulness of research hypothesis based on the accuracy of research evidence and hypothesis, and decisions, the goal of which is to enable optimal decision-making under present and specific circumstances. To optimize the chance of both correct conclusions and correct decisions, the synthesis of all major statistical approaches to clinical research is needed. The integration of these approaches (frequentist, Bayesian, and decision-analytic) can be accomplished through formal risk:benefit (R:B) analysis. This chapter illustrates the rational choice of a research hypothesis using R:B analysis based on decision-theoretic expected utility theory framework and the concept of "acceptable regret" to calculate the threshold probability of the "truth" above which the benefit of accepting a research hypothesis outweighs its risks.

Mesh:

Year:  2008        PMID: 18582621     DOI: 10.1053/j.seminhematol.2008.04.006

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  6 in total

1.  Uncertainty and equipoise: at interplay between epistemology, decision making and ethics.

Authors:  Benjamin Djulbegovic
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

Review 2.  Optimism bias leads to inconclusive results-an empirical study.

Authors:  Benjamin Djulbegovic; Ambuj Kumar; Anja Magazin; Anneke T Schroen; Heloisa Soares; Iztok Hozo; Mike Clarke; Daniel Sargent; Michael J Schell
Journal:  J Clin Epidemiol       Date:  2010-12-16       Impact factor: 6.437

3.  A regret theory approach to decision curve analysis: a novel method for eliciting decision makers' preferences and decision-making.

Authors:  Athanasios Tsalatsanis; Iztok Hozo; Andrew Vickers; Benjamin Djulbegovic
Journal:  BMC Med Inform Decis Mak       Date:  2010-09-16       Impact factor: 2.796

4.  Taking the long view: how to design a series of Phase III trials to maximize cumulative therapeutic benefit.

Authors:  Marie-Cécile Le Deley; Karla V Ballman; Julien Marandet; Daniel Sargent
Journal:  Clin Trials       Date:  2012-05-08       Impact factor: 2.486

5.  Evidence-based medicine in times of crisis.

Authors:  Benjamin Djulbegovic; Gordon Guyatt
Journal:  J Clin Epidemiol       Date:  2020-07-10       Impact factor: 6.437

6.  Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.

Authors:  Małgorzata Dawidowska; Maria Kosmalska; Łukasz Sędek; Aleksandra Szczepankiewicz; Magdalena Twardoch; Alicja Sonsala; Bronisława Szarzyńska-Zawadzka; Katarzyna Derwich; Monika Lejman; Katarzyna Pawelec; Agnieszka Obitko-Płudowska; Katarzyna Pawińska-Wąsikowska; Kinga Kwiecińska; Andrzej Kołtan; Agnieszka Dyla; Władysław Grzeszczak; Jerzy R Kowalczyk; Tomasz Szczepański; Ewa Ziętkiewicz; Michał Witt
Journal:  Sci Rep       Date:  2016-07-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.